UnitedHealth's Profits Exposed: Study Reveals Four-Fold Increase in Profit Margins

A recent study commissioned by Insurance Watchdog Coalition revealed that UnitedHealth Group's (UHG) profit margins were significantly higher than what the company claimed. According to the study, when pass-through medical costs are excluded from its revenue, UHG's operating profit margin averaged 33.0% of gross profit from 2020 to 2025.

This is four times higher than the average net margin of 7.6% claimed by UnitedHealth Group. The study also found that $26.4 billion was behind the company's 'shell game' of counting funds used to pay medical claims as revenue.

Economist Nam D. Pham, Ph.D., conducted the study and found that UHG's profit margins are comparable to those of top pharmaceutical companies in the country. In fact, the biopharmaceutical manufacturers collectively reinvested nearly 52% of operating costs into research and development (R&D), while UHG devoted 93% of its operating costs to selling, general, and administrative expenses.

The findings suggest that common comparisons of profit margins can understate the profitability of health insurers relative to biopharmaceutical manufacturers. This has significant implications for policy makers and regulators looking to reform the healthcare industry.